Market Overview:
The global breast cancer testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of breast cancer, technological advancements in breast cancer diagnosis and treatment, and rising awareness about early detection of breast cancer. The global market for screening tests, diagnostic tests, and monitoring tests is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into screening tests, diagnostic tests,,and monitoring tests. Screening testss are further sub-segmented into mammography,,ultrasound,,and magnetic resonance imaging (MRI).On the basis of application,.the market is segmented into non-invasive breast cancer and invasive breast cancer. Non-invasivebreast cancers are further sub-segmented into ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). Invasivebreast cancers are further sub-segmentedinto estrogen receptor positive (ER+) tumors,.estrogen receptor negative(ER-) tumors,.progesterone receptor positive(PR+) tumors,.
Product Definition:
Breast cancer testing is a medical procedure used to screen for or diagnose breast cancer. It involves the examination of tissue or fluid taken from the breast. The importance of breast cancer testing is that it can help find and diagnose the disease early, when treatment is most likely to be successful.
Screening Tests:
Breast cancer is one of the most common types of cancer diagnosed among women. According to the World Health Organization (WHO), breast cancer is considered as one of the leading causes for deaths in women around the world. The American Cancer Society estimates that over227,4050 new cases would be diagnosed in 2018 and more than 42,000 deaths would occur due to this disease.
Diagnostic Tests:
A diagnostic test is a procedure or series of procedures used to obtain and evaluate information in order to make a diagnosis. In oncology, diagnostic tests are used for the detection of cancer-causing pathogens or genetic mutations. The most common types of tests include biopsy, blood tests (such as CA-125), imaging scans such as MRI and X-ray, bone density testing along with tissue biopsy for surgical planning purposes.
Application Insights:
In 2017, the non-invasive breast cancer segment dominated the market with a share of over 60.0% in terms of revenue. Non-invasive breast cancer includes ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). DCIS is characterized by abnormal cells that are found in the milk ducts whereas IDC is characterized by malignant growth within the mammary gland. The increasing prevalence of hormonal imbalance such as late onset of menopause and postmenopausal women¢â‚¬â„¢s health issues are some factors contributing to segment growth during forecast years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to various factors such as high healthcare expenditure, presence of key players, and increasing awareness about breast cancer screening tests. Moreover, government initiatives for early diagnosis are expected to fuel the regional growth over the forecast period. For instance, according to Breastcancer.org; In October 2018, The FDA has approved two new blood tests that can help detect mutations in genes associated with hereditary breast cancer (HBC) more than ever before-up until now there were no genetic tests available for HBC susceptibility except through a biopsy or tissue sample which is invasive and carries a higher risk of leading to secondary cancers than necessary diagnostic procedures.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels coupled with growing health awareness among people especially women population aged 35 years & above resulting into increased demand for oncological screening services.
Growth Factors:
- Increasing incidence of breast cancer: The incidence of breast cancer is increasing at a rapid pace across the globe. This is primarily attributed to the changing lifestyle and dietary habits. According to the American Cancer Society, around 1 in 8 women in the U.S. will develop invasive breast cancer during their lifetime.
- Growing awareness about early detection and screening: There is a growing awareness among women about the importance of early detection and screening for breast cancer. This has led to an increase in demand for Breast Cancer Testing products and services worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Breast Cancer Testing Market Research Report
By Type
Screening Tests, Diagnostic Tests, Monitoring Tests
By Application
Non-invasive Breast Cancer, Invasive Breast Cancer
By Companies
Abbott, Alere, Becton Dickinson, BioMerieux, Roche, GE Healthcare, Hologic, Philips, PerkinElmer, Quest Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
224
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Breast Cancer Testing Market Report Segments:
The global Breast Cancer Testing market is segmented on the basis of:
Types
Screening Tests, Diagnostic Tests, Monitoring Tests
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Non-invasive Breast Cancer, Invasive Breast Cancer
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Alere
- Becton Dickinson
- BioMerieux
- Roche
- GE Healthcare
- Hologic
- Philips
- PerkinElmer
- Quest Diagnostics
Highlights of The Breast Cancer Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Screening Tests
- Diagnostic Tests
- Monitoring Tests
- By Application:
- Non-invasive Breast Cancer
- Invasive Breast Cancer
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Breast Cancer Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Breast cancer testing is a process by which a doctor can determine if you have breast cancer. This process includes taking a medical history, doing an exam of your breasts, and ordering tests to look for signs of the disease.
Some of the key players operating in the breast cancer testing market are Abbott, Alere, Becton Dickinson, BioMerieux, Roche, GE Healthcare, Hologic, Philips, PerkinElmer, Quest Diagnostics.
The breast cancer testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Breast Cancer Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Breast Cancer Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Breast Cancer Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Breast Cancer Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Breast Cancer Testing Market Size & Forecast, 2018-2028
4.5.1 Breast Cancer Testing Market Size and Y-o-Y Growth
4.5.2 Breast Cancer Testing Market Absolute $ Opportunity
Chapter 5 Global Breast Cancer Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Breast Cancer Testing Market Size Forecast by Type
5.2.1 Screening Tests
5.2.2 Diagnostic Tests
5.2.3 Monitoring Tests
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Breast Cancer Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Breast Cancer Testing Market Size Forecast by Applications
6.2.1 Non-invasive Breast Cancer
6.2.2 Invasive Breast Cancer
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Breast Cancer Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Breast Cancer Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Breast Cancer Testing Analysis and Forecast
9.1 Introduction
9.2 North America Breast Cancer Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Breast Cancer Testing Market Size Forecast by Type
9.6.1 Screening Tests
9.6.2 Diagnostic Tests
9.6.3 Monitoring Tests
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Breast Cancer Testing Market Size Forecast by Applications
9.10.1 Non-invasive Breast Cancer
9.10.2 Invasive Breast Cancer
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Breast Cancer Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Breast Cancer Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Breast Cancer Testing Market Size Forecast by Type
10.6.1 Screening Tests
10.6.2 Diagnostic Tests
10.6.3 Monitoring Tests
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Breast Cancer Testing Market Size Forecast by Applications
10.10.1 Non-invasive Breast Cancer
10.10.2 Invasive Breast Cancer
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Breast Cancer Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Breast Cancer Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Breast Cancer Testing Market Size Forecast by Type
11.6.1 Screening Tests
11.6.2 Diagnostic Tests
11.6.3 Monitoring Tests
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Breast Cancer Testing Market Size Forecast by Applications
11.10.1 Non-invasive Breast Cancer
11.10.2 Invasive Breast Cancer
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Breast Cancer Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Breast Cancer Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Breast Cancer Testing Market Size Forecast by Type
12.6.1 Screening Tests
12.6.2 Diagnostic Tests
12.6.3 Monitoring Tests
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Breast Cancer Testing Market Size Forecast by Applications
12.10.1 Non-invasive Breast Cancer
12.10.2 Invasive Breast Cancer
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Breast Cancer Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Breast Cancer Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Breast Cancer Testing Market Size Forecast by Type
13.6.1 Screening Tests
13.6.2 Diagnostic Tests
13.6.3 Monitoring Tests
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Breast Cancer Testing Market Size Forecast by Applications
13.10.1 Non-invasive Breast Cancer
13.10.2 Invasive Breast Cancer
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Breast Cancer Testing Market: Competitive Dashboard
14.2 Global Breast Cancer Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Alere
14.3.3 Becton Dickinson
14.3.4 BioMerieux
14.3.5 Roche
14.3.6 GE Healthcare
14.3.7 Hologic
14.3.8 Philips
14.3.9 PerkinElmer
14.3.10 Quest Diagnostics
